# Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)

> **NCT04750629** · — · COMPLETED · sponsor: **Lumos Diagnostics** · enrollment: 140 (actual)

## Conditions studied

- SARS-CoV-2
- Covid19

## Interventions

- **DEVICE:** POC CoviDx™ Rapid Antigen Test

## Key facts

- **NCT ID:** NCT04750629
- **Lead sponsor:** Lumos Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-08
- **Primary completion:** 2021-05-07
- **Final completion:** 2021-05-14
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04750629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04750629, "Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04750629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*